Home » Newsletters » BioWorld Science

BioWorld Science

March 17, 2020

View Archived Issues

Repurposing human kinase inhibitors and optimization against drug-resistant S. aureus

BioNTech reports on mRNA vaccine candidate BNT-162 for COVID-19

GOF, LOF mutations take different paths to same result

Promising final phase IIa results presented for IPED-2015 in erectile dysfunction

Results of phase I study of V-934/V-935 hTERT vaccination in patients with selected solid tumors

Octapeptide binds to pANXA2 with calcium-dependent affinity in solid tumors: a new imaging probe

Cerebrospinal fluid cytokines CXCL10/IP-10 and IL-21 can help to diagnose autoimmune encephalitis

Data presented from part 1 of phase II PIONEER study of avapritinib in systemic mastocytosis

Shenzhen Bo Li Jian Medicine presents new IRAK-4 inhibitors

LATS1/LATS2 inhibitors described by Nivien Therapeutics

New enteropeptidase inhibitors identified at SCOHIA PHARMA

Tera Stone discovers xanthine oxidase inhibitors

Menin/MLL interaction inhibitors patented by Sumitomo Dainippon Pharma

XORTX launches new program to treat COVID-19

Galectin-7 as new therapeutic target for the prevention of preeclampsia

GRMS-55 and lisofylline demonstrate promising activity in models of immune-related disorders

First-in-human study evaluates SRK-181 for locally advanced or metastatic solid tumors

COVID-19: Undetected cases are major source of pandemic spread

Relief Therapeutics to study aviptadil for ARDS in patients with COVID-19

NIH doses first patient in phase I study of Moderna's mRNA-1273 against SARS-CoV-2

Novo Nordisk announces decision to pause concizumab trials in hemophilia

InxMed initiates phase Ib trial of IN-10018 for uveal melanoma and NRAS-mutant metastatic melanoma

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 11, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...